» Articles » PMID: 9529358

Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1998 Jun 13
PMID 9529358
Citations 358
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed a real-time quantitative PCR assay to measure the concentration of fetal DNA in maternal plasma and serum. Our results show that fetal DNA is present in high concentrations in maternal plasma, reaching a mean of 25.4 genome equivalents/ml (range 3.3-69. 4) in early pregnancy and 292.2 genome equivalents/ml (range 76. 9-769) in late pregnancy. These concentrations correspond to 3.4% (range 0.39%-11.9%) and 6.2% (range 2.33%-11.4%) of the total plasma DNA in early and late pregnancy, respectively. Sequential follow-up study of women who conceived by in vitro fertilization shows that fetal DNA can be detected in maternal serum as early as the 7th wk of gestation and that it then increases in concentration as pregnancy progresses. These data suggest that fetal DNA can be readily detected in maternal plasma and serum and may be a valuable source of material for noninvasive prenatal diagnosis.

Citing Articles

Preeclampsia risk prediction from prenatal cell-free DNA screening.

Adil M, Kolarova T, Doebley A, Chen L, Tobey C, Galipeau P Nat Med. 2025; .

PMID: 39939524 DOI: 10.1038/s41591-025-03509-w.


Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report.

Balaguer N, Mateu-Brull E, Martinez-Conejero J, Cervero A, Navarro R, Jimenez-Almazan J Front Genet. 2025; 15:1502287.

PMID: 39902298 PMC: 11788280. DOI: 10.3389/fgene.2024.1502287.


Non-Invasive Determination of the Paternal Inheritance in Pregnancies at Risk for β-Thalassaemia by Analyzing Cell-Free Fetal DNA Using Targeted Next-Generation Sequencing.

Byrou S, Brouwer R, Tomazou M, Tamana S, Kountouris P, Lederer C Int J Mol Sci. 2025; 26(2).

PMID: 39859286 PMC: 11765003. DOI: 10.3390/ijms26020570.


Artificial intelligence and machine learning in cell-free-DNA-based diagnostics.

Tsui W, Ding S, Jiang P, Lo Y Genome Res. 2025; 35(1):1-19.

PMID: 39843210 PMC: 11789496. DOI: 10.1101/gr.278413.123.


Non-invasive prenatal diagnosis (NIPD): current and emerging technologies.

Hanson B, Paternoster B, Povarnitsyn N, Scotchman E, Chitty L, Chandler N Extracell Vesicles Circ Nucl Acids. 2024; 4(1):3-26.

PMID: 39698301 PMC: 11648410. DOI: 10.20517/evcna.2022.44.